Species-specific, postentry barriers to primate immunodeficiency virus infection.
about
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cellsProteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infectionSpecific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factorFunctional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domainsTrim5alpha protein restricts both HIV-1 and murine leukemia virusThe human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activitiesRetrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alphaIn defense of the cell: TRIM5alpha interception of mammalian retrovirusesFibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancerAll three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restrictionNovel Escape Mutants Suggest an Extensive TRIM5α Binding Site Spanning the Entire Outer Surface of the Murine Leukemia Virus Capsid ProteinLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationA rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmiesSIV replication in human cellsStoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.Proteasomal degradation of TRIM5alpha during retrovirus restrictionMultiple blocks to human immunodeficiency virus type 1 replication in rodent cellsIn vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector.Retrovirus restriction by TRIM5alpha variants from Old World and New World primatesStabilized human TRIM5α protects human T cells from HIV-1 infection.Hsp70 interacts with the retroviral restriction factor TRIM5alpha and assists the folding of TRIM5alphaResidues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primatesCharacterization of a core fragment of the rhesus monkey TRIM5α protein.The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restrictionEnvelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro.Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGNRetroviral restriction factor TRIM5alpha is a trimerAn intracellular block to primate lentivirus replication.Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropismRestriction of lentivirus in monkeysA dominant block to HIV-1 replication at reverse transcription in simian cellsInteraction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5αHigh natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
P2860
Q24536359-194BADF6-8E9F-4F6C-BE00-0B112DF1EBE8Q24544232-7A4526F5-B6D4-4FBE-AD6A-6BC140BD36A0Q24547409-31F8607D-AE21-4D3D-AF77-7F2E7ECBFD09Q24548932-2F819E06-F945-489F-8D93-BD00EB16C2F4Q24561922-B3A35932-5729-43E1-9168-43894379B0D3Q24561930-815718D7-969A-4AB9-8912-081BFBD14C7AQ24561939-823E9BF5-3E8B-4FE6-B07E-CD3D781B832DQ24561978-2CD6855F-ECFF-4463-B4C7-413AB9269581Q24654629-7C9247DD-2FC8-42D1-A0C9-DB65BD353B08Q24673961-B26D88F8-03DB-45AF-A4D6-FB37BCEF7D77Q27667494-7B482C73-5C30-4A0F-A9A5-D750C3960444Q28546614-9944F47B-3024-4DAA-9263-6F6D514528A3Q30378660-DDE60813-FAD1-4D5F-81B1-11661EE97BF3Q30417737-5ED1CF53-DE1A-4934-BAF2-D719606AFC07Q30447936-08B3C437-857D-4A47-B7E5-854D1E9AEEFCQ30883515-83EAD91F-EAA0-492C-89B1-508DF65AE78EQ33337129-523AB772-22C7-465A-900F-85384623C308Q33603453-2049A53E-5B52-41FF-A6C3-2174B34A70ADQ33691863-3B35E4B4-A398-4DB0-87C0-5CEAEEEEF62BQ33707501-3113E07B-695A-49C3-B957-CD464F144AFDQ33724266-09705164-7EAB-40D3-AC1E-79C3F7F779B3Q33748257-FDB452EB-5E26-4C7A-BB42-8E36C9F0C7EDQ33780547-E68F0423-7D41-4BD2-B05D-C09E7C9F0829Q33780572-C1A8AB87-C1FC-4694-A996-274FD17FC2E9Q33785434-050C92FA-CE5C-4C96-9A27-3382028E9090Q33826504-59809F24-52EB-4AB9-A3FE-BD7BD2435B7AQ33834617-81985B08-79BD-490E-830F-97C08E052BACQ33839485-13A79C02-2F3E-4247-B178-D42F5D4C2113Q33847458-1EB33CB8-5C52-4C7D-96AF-05A68745CA15Q33848931-F3015F0A-F52F-4F17-90DE-5761C77872D0Q34010226-5F8BE03E-93D9-4D5F-B98F-44E60636BEF4Q34123929-1C9D6B7A-2C14-458C-BC69-9F72F7A2F817Q34153599-BD6CA3A3-6174-448F-AD12-C697B5816F83Q34154693-C8D4D6FA-A921-4A09-A0F5-350788C65FF0Q34154725-3502D886-A32C-4FE4-981D-20B516B57EE2Q34161825-F5C8B249-6307-4233-B0E0-C4D8415098C9Q34232978-76A3F07F-0004-4603-AE6A-04E900929B11Q34288181-ACA62CFD-B43B-44A1-9573-F31718E7A904Q34291018-7EE139DE-AF10-4544-BB6E-AC68C2720862Q34335096-DC977AE4-9542-4942-A7AF-4875001672D6
P2860
Species-specific, postentry barriers to primate immunodeficiency virus infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@ast
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@en
type
label
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@ast
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@en
prefLabel
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@ast
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@en
P2093
P2860
P1433
P1476
Species-specific, postentry barriers to primate immunodeficiency virus infection.
@en
P2093
D Schubert
J Scammell
P Ferrigno
P2860
P304
10020-10028
P577
1999-12-01T00:00:00Z